Donor Skin Patch Offers Early Detection for Lung Transplant Rejection
A groundbreaking medical trial in the UK is using skin patches from organ donors to provide an early warning system for lung transplant rejection. The innovative technique, which involves grafting a small piece of donor skin onto a patient's forearm, has already helped detect rejection in its initial stages, allowing for prompt treatment and potentially saving transplanted organs.
The Sentinel Trial and Its First Beneficiaries
Darren White, a 53-year-old former bus driver from Stockton-on-Tees, is among the first lung transplant patients in the UK to participate in the Sentinel trial. More than a year after his transplant in late 2024, Mr White is thriving and enjoying simple pleasures like walking his three-year-old son Daniel to the park—activities that were impossible before due to his lung fibrosis diagnosis.
The trial involves grafting a 10cm by 3cm skin patch from the organ donor onto the recipient's forearm during the transplant surgery. This skin patch acts as a crucial "window" into the body's response to the new organ. Scientists believe that skin shows signs of rejection earlier and more visibly than internal organs like lungs, enabling medical teams to intervene at the first sign of trouble.
How the Skin Patch Saved a Transplant
Three months after his transplant, Mr White noticed a purple rash developing on the skin patch on his forearm. He immediately sent photographs to his medical team, who conducted a biopsy that confirmed mild rejection. He was promptly treated with steroids, which successfully halted the rejection process.
"I definitely believe the skin patch helped to stop the lungs from being rejected," Mr White said. "I was feeling fine, there was no reason for me to think that the lungs were being rejected—the only sign was the rash. I'm over a year post-transplant now and doing really well. Who knows if that would be the case if the rash hadn't shown up and rejection wasn't spotted until further down the line."
The Challenge of Detecting Lung Rejection
According to NHS Blood and Transplant (NHSBT), detecting lung rejection is notoriously difficult. Traditional methods involve blood tests, biopsies, and X-rays, which may not catch rejection until significant damage has occurred. Rejection rates are highest in the first three to six months after surgery, affecting almost one-third of transplant patients.
Mr White emphasized the psychological impact: "Rejection is the biggest fear of any transplant recipient, so having something that might be able to catch it much sooner than otherwise was really appealing. Anything that might help to avoid rejection was worth a try."
Expanding the Trial and Future Implications
The Sentinel trial is scheduled to run until 2027 and will recruit 152 patients across five specialist centres: Freeman Hospital, Harefield Hospital, Queen Elizabeth Hospital, Royal Papworth, and Wythenshawe Hospital. The skin grafts are performed by plastic surgeons at the University of Oxford, with consent from donor families obtained through NHSBT specialist nurses.
Henk Giele, chief investigator of Sentinel and an Oxford plastic surgeon, explained: "It seems logical that having a window to your transplant can provide an early warning system of rejection or reassure you that you don't have rejection, but we have to prove it works. We hope it will change what we know about transplant and make patients' lives better and longer."
Professor Andrew Fisher, a respiratory transplant medicine expert at Newcastle University, added: "If successful, this approach has the potential to revolutionise the way lung transplants are performed in the future and reduce the problems with detecting and treating rejection early, which is vital."
A New Lease on Life
For Darren White, the benefits extend far beyond medical monitoring. "The biggest difference is I can walk, I can take Daniel to the park to play," he said. "Before, he could sit on my knee, drive my buggy, but that was it—I couldn't do much with him. I can be more of a dad now. My favourite thing is to go to the park. Daniel always asks to go on the swing, and we have one in our garden. I can push him now. It's the simple things that are the best."
Emma Lawson, organ donation innovation and research lead at NHSBT, highlighted the collaborative effort: "Thanks to the generosity of amazing donor families providing additional consent for skin grafts, patients are now receiving them, and we are privileged to work alongside them to enable this important trial to go ahead."
This pioneering method builds on previous use in intestinal transplant patients and represents a significant step forward in transplant medicine, offering hope for earlier intervention and improved long-term outcomes for organ recipients across the UK.
